Published in Obesity and Diabetes Week, March 22nd, 2004
The Jacksonville, Florida-based company says safety is the main reason it will drop the $30,000-surgery, also known as stomach stapling, which is considered a last resort for morbidly obese people trying to lose weight.
Robert Forster, MD, the company's chief medical officer and vice president for healthcare services, said about 3 in every 1,000 patients die and up to 20% of patients return to the hospital for a second procedure.
There has also been a spike in demand for the surgery, which would have cost the insurer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.